FDA Inspection 1056836 — Dana-Farber Harvard Cancer Center

Dana-Farber Harvard Cancer Center — FEI 3008782635

The FDA completed an inspection of Dana-Farber Harvard Cancer Center on Apr 25, 2018 in Boston, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.